Antibe Therapeutics Inc. (ATBPF) has a market capitalization of $11.43M and trades at $0.22. The 52-week range is 0.1889-0.216.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -0.6, Earnings Per Share (EPS) of $-0.37.
The stock has a beta of 0.58, operates in the Healthcare sector.
